Thyroid function and serum hepatic enzyme activity in dogs after phenobarbital administration

Area of Science:

• Veterinary Pharmacology
• Canine Endocrinology
• Hepatology

Background:

• Phenobarbital is a common treatment for canine epilepsy.
• It is known to affect liver enzyme activity and thyroid hormone levels.
• The duration of these effects after drug cessation is not well understood.

Purpose of the Study:

• To investigate the time course of changes in thyroid hormones (TT4, FT4, TSH), cholesterol, albumin, and liver enzymes (ALT, ALP, GGT) after discontinuing long-term phenobarbital in healthy dogs.

Main Methods:

• Twelve healthy dogs received phenobarbital for 27 weeks.
• Blood samples were collected before treatment, at the end of treatment, and weekly for 10 weeks post-treatment.
• Serum biochemical and hormonal parameters were analyzed.

Main Results:

• Phenobarbital increased ALT, ALP, TSH, and cholesterol, while decreasing TT4 and FT4.
• Thyroid function estimates normalized within 1-4 weeks post-phenobarbital.
• Liver enzyme and cholesterol changes resolved within 3-5 weeks.

Conclusions:

• Thyroid testing in dogs on or recently off phenobarbital requires careful timing (at least 4 weeks post-discontinuation) to avoid misinterpretation.
• Persistent elevations in liver enzymes 6-8 weeks after stopping phenobarbital may signal underlying hepatic disease.